Updated:
Peppermint VenturePartners
Peppermint VenturePartners (PVP) is a private Venture Capital firm based in Berlin, Germany. Grown out of Peppermint Holding, a mid-sized industry group, it is...
Peppermint VenturePartners
Peppermint VenturePartners (PVP) is a private Venture Capital firm based in Berlin, Germany. Grown out of Peppermint Holding, a mid-sized industry group, it is dedicated to supporting outstanding entrepreneurs and innovative scientists in transforming life science. Along the continuum of care, it invests in disruptive and novel solutions for efficiency, accessibility, cost containment, and digitization of healthcare and life science. It invests in life sciences companies primarily in Europe with a focus on disruptive innovations.
General information
Firm type
Venture Capital
Year founded
2010
Location
Region
Europe
Country
Germany
City
Berlin
Corporate office
Kurfürstendamm 194, 10707 Berlin, Germany
Principals
Ingeborg Neumann
Managing Partner
Dr. Joachim Rautter
Managing Partner
Dr. Klaus Stöckemann
Managing Partner
Sector focus
Frequently asked questions
How does Peppermint VenturePartners source its deal flow?
PVP’s pipeline is built on formal partnerships with Charité – Universitätsmedizin Berlin and the Helmholtz Association. The firm’s CBF 1 fund uses the Charité network to translate medical research into startups, while its sister company PVP Advisors externally manages the Helmholtz Validation Fund, which screens projects across 18 national labs with an annual budget exceeding €5 billion. PVP partners also serve as judges and mentors in EIT Health and EIC Accelerator programs.
Does PVP participate in fund commitments or only direct deals?
PVP invests directly into portfolio companies from its own fund vehicles. The firm does not act as a fund-of-funds manager. Co-investment is a central feature: CBF 1 portfolio companies have attracted €185 million from global co-investors alongside PVP’s initial capital.
How is PVP related to Peppermint Holding?
Peppermint Holding is the mid-sized industrial group founded by Ingeborg Neumann in 1997, active in high-end textiles. The first venture capital fund was launched within the holding in 2000. In 2010, Peppermint VenturePartners was relaunched as a separate, independent fund management entity, though Neumann remains the common principal across both entities.
What is the status of the LIIDO fund?
LIIDO — Laboratory Intelligence Innovations Digitalization and Operations — is a planned €100 million fund that PVP aims to launch in 2025. It will focus on life science tools and services companies in Europe, prioritizing DACH, the UK, and Scandinavia. The strategy emphasizes providing go-to-market expertise to portfolio companies with existing revenue traction.
Who runs investment decisions at PVP?
Investment decisions are led by the three managing partners: Ingeborg Neumann, Dr. Joachim Rautter, and Dr. Klaus Stöckemann. Neumann provides the entrepreneurial and holding-company oversight; Rautter chairs several portfolio company boards and led earlier PVP investment activities; Stöckemann brings 20 years of venture experience, including a prior role as general partner in 3i’s international healthcare team.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: